Global Cardiopulmonary Bypass Equipment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Cardiopulmonary Bypass Equipment is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The Cardiopulmonary Bypass Equipment is also called a heart-lung machine. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation. Scope of the Report: Cardiopulmonary Bypass Equipment market is mainly occupied by large companies, Sorin as the largest player in the market produced over 53% of Cardiopulmonary Bypass Equipment and made more than 56% of revenue share in 2015. MAQUET followed as second produced about 13% in 2015. Europe is a major production area and it produced about 60% of Cardiopulmonary Bypass Equipment in 2015. North America produced about 20% of Cardiopulmonary Bypass Equipment in 2015. North America is a major consumption area and it produced about 42% of Cardiopulmonary Bypass Equipment in 2015. The second place is Europe; following North America with the sales market share over 32%. China is another important market of, enjoying 8% sales market share in 2015. The worldwide market for Cardiopulmonary Bypass Equipment is expected to grow at a CAGR of roughly 9.8% over the next five years, will reach 500 million US$ in 2024, from 290 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Cardiopulmonary Bypass Equipment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions ...
Table of Contents 1 Market Overview 1.1 Cardiopulmonary Bypass Equipment Introduction 1.2 Market Analysis by Type 1.2.1 Single Roller Pump Cardiopulmonary Bypass Equipment 1.2.2 Double Roller Pump Cardiopulmonary Bypass Equipment 1.3 Market Analysis by Applications 1.3.1 Cardiac Surgery 1.3.2 Lung Transplant Operation 1.3.3 Acute Respiratory Failure Treatment 1.3.4 Other 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) ...
8542

1379

OUR CLIENT